Eco R1 Capital, LLC Geron Corp Transaction History

Eco R1 Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $3.5 Million - $4.18 Million	1,726,527 Added 75.0%	4,028,507 $9.75 Million
Q3 2022 Nov 14, 2022	SELL	$1.67 - $2.94 $19.8 Million - $34.9 Million	-11,867,008 Reduced 83.75%	2,301,980 $5.39 Million
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.65 $138,903 - $192,597	-116,726 Reduced 0.82%	14,168,988 $22 Million
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $14.1 Million - $22.9 Million	14,285,714 New	14,285,714 $19.4 Million
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $28.8 Million - $39.8 Million	-18,939,925 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.05 $450,808 - $596,230	-290,844 Reduced 1.51%	18,939,925 $30.1 Million
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $20.2 Million - $41.9 Million	19,230,769 New	19,230,769 $41.9 Million
Q2 2018 Aug 14, 2018	SELL	$3.29 - $4.82 $1.15 Million - $1.69 Million	-350,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $633,500 - $2.09 Million	350,000 New	350,000 $1.49 Million

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.